✦ LIBER ✦

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma

✍ Scribed by Philip C. Mack; David R. Gandara; Alvin H. Lau; Primo N. Lara; Martin J. Edelman; Paul H. Gumerlock

Publisher: Springer
Year: 2003
Tongue: English
Weight: 545 KB
Volume: 51
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0571-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulation of cell cycle-related protein

Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines

✍ Cinzia Pellizzaro; Danila Coradini; Antonella Daniotti; Gabriella Abolafio; Mari 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 79 KB 👁 2 views

Cisplatin, etoposide, and mitomycin in t

Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study

✍ Stephen Davis; Maurizio Tomato; Lucio Crino; Mari Antonetta Colozza; Kenneth Lub 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

A total of 39 patients with non-small cell carcinoma of the lung (NSCL) were treated with cisplatin, etoposide, and mitomycin. A major response rate (complete response + partial response) was seen in 15 patients (39%). Median survival for all patients was 340 days; median survival of the responding

Therapeutic efficacy and pharmacokinetic

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma

✍ Joachim Z. Fuks; Merrill J. Egorin; Joseph Aisner; David A. Echo; Stanley Ostrow 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 480 KB

Twenty-nine patients with non-small cell lung cancer refractory to prior therapy were treated with either vindesine (VDS) alone (3 mg/m2 every week) or the combination of VDS plus cisplatin (DDP) (100 mg/m2 every 28 days). Serial blood and urine samples were collected to assess the pharmacokinetics

Up-regulation of ICH-1lprotein by thromb

Up-regulation of ICH-1lprotein by thromboxane A2antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines

✍ Masaki Fujimura; Kazuo Kasahara; Hiroki Shirasaki; Utako Heki; Keiichi Iwasa; Ak 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

In vitro enhancement of fluoropyrimidine

In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines

✍ Yoshikazu Sugimoto; Yuichiro Ohe; Kazuto Nishio; Tohru Ohmori; Yasuhiro Fujiwara 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 755 KB

Induction of apoptosis in human non-smal

Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437

✍ Shi-Yong Sun; Ping Yue; Braham Shroot; Waun K. Hong; Reuben Lotan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

Retinoids are promising agents for the prevention and treatment of several human malignancies including lung cancer. However, many lung cancer cell lines are resistant to the growth inhibitory effects of all-trans-retinoic acid (ATRA). Recently, we found that a new synthetic retinoid, 6-[3-(1-adaman